# Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

> **NCT05224115** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 6 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **OTHER:** [11C]CHDI-00485180-R
- **OTHER:** [11C]CHDI-00485626

## Key facts

- **NCT ID:** NCT05224115
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-17
- **Primary completion:** 2020-10-13
- **Final completion:** 2020-10-13
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224115, "Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05224115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*